Results 141 to 150 of about 2,075 (191)
Passive Immunisation in the Treatment of Infectious Diseases Related to Highly Potent Bacterial Toxins. [PDF]
BiomedicinesPrygiel M +3 more
europepmc +1 more source
Pattern and impact of antidotal administration in an Egyptian tertiary poison control center: A three-year retrospective study (2021-2023). [PDF]
Toxicol RepEl-Sarnagawy GN +2 more
europepmc +1 more source
Cauda equina nerve root enhancement in adult intestinal toxemia botulism. [PDF]
BMC NeurolJiang R +4 more
europepmc +1 more source
Infant botulism in Australia: availability of human botulinum antitoxin for treatment [PDF]
Medical Journal of Australia, 2010 We report the first Australian case of treatment of infant botulism with a human botulinum antitoxin developed in the United States by the California Department of Public Health. Our patient's clinical improvement was rapid, and although the product is expensive, cost-analysis supports the economical viability of its use.
May, M. L. A. +2 more
openaire +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Antitoxin therapy for botulinum intoxication
Reviews in Medical Microbiology, 2001Botulinum toxin is the most toxic substance known to mankind. It is involved in infant botulism, classical food-borne botulism, wound botulism, and is a threat in biological warfare or bioterrorism.
Carl N. Mayers +2 more
exaly +2 more sources
Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin
Toxicon, 2001The neutralization of botulinum toxin serotype A with polyclonal equine antitoxin was studied in isolated mouse hemidiaphragms and compared to the same action in live mice. The biological activity of the toxin in the isolated muscle could be markedly reduced with excess antitoxin, estimated as 3:1 molar ratios of IgG Ab:toxin or better.
R E Sheridan, S S Deshpande
exaly +3 more sources
Clinical Immunology, 2010
To produce a vaccine suitable for human use, a recombinant non His-tagged isoform of the Hc domain of botulinum neurotoxin serotype F (rFHc) was expressed in Escherichia coli and purified by sequential chromatography. The rFHc was evaluated as a subunit vaccine candidate in mouse model of botulism.
Yunzhou Yu, Wei-Yuan Yu, Zhi-Wei Sun
exaly +3 more sources
To produce a vaccine suitable for human use, a recombinant non His-tagged isoform of the Hc domain of botulinum neurotoxin serotype F (rFHc) was expressed in Escherichia coli and purified by sequential chromatography. The rFHc was evaluated as a subunit vaccine candidate in mouse model of botulism.
Yunzhou Yu, Wei-Yuan Yu, Zhi-Wei Sun
exaly +3 more sources
Toxicon, 2016
Japanese botulinum antitoxins have been used for more than 50 years; however, their safety and therapeutic efficacy are not clear. In order to analyze the available data on botulinum antitoxin therapy in Japan, we surveyed published reports about botulism cases in which botulinum antitoxins were used, and retrospectively analyzed the safety and ...
Yasushi Torii +2 more
exaly +3 more sources
Japanese botulinum antitoxins have been used for more than 50 years; however, their safety and therapeutic efficacy are not clear. In order to analyze the available data on botulinum antitoxin therapy in Japan, we surveyed published reports about botulism cases in which botulinum antitoxins were used, and retrospectively analyzed the safety and ...
Yasushi Torii +2 more
exaly +3 more sources